Home » Topics » BioWorld Science

BioWorld Science
RSS

RUNX1 targeting shows promise for treating aggressive PDAC

March 3, 2022

Researchers present CX-10759 anti-IgE antibody for hypersensitivity

March 3, 2022

Targeting PD-1/PD-L1 pathway prevents allergic immune response

March 2, 2022

Neuropathy may unify disparate long COVID symptoms

March 2, 2022

HuR ablation ameliorates allergen-induced asthmatic symptoms

March 2, 2022

LIGHT mediates esophageal remodeling in murine model of eosinophilic esophagitis

March 2, 2022

Quanterix collaborates with Lilly on diagnosis and treatment of Alzheimer's disease

March 2, 2022

JAK1 activation of sensory neurons suppresses lung inflammation

March 2, 2022

HLA-DPB1*05:01 allele predicts nonresponse to SLIT in allergic rhinitis

March 2, 2022

SIGLEC-6 targeting inhibits human mast cell degranulation and anaphylaxis

March 2, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...